People

Inhaled drug developer Alexza Pharmaceuticals has announced the promotions of Edwin S. Kamemoto to Executive VP, R&D and Quality and Lori H. Takahashi to VP, Pharmaceutical R&D and Quality. Both positions are newly created. Kamemoto joined Alexza in 2006 and was most recently Senior VP, Regulatory Affairs. Takahashi joined Alexza in 2005 and most recently served as … [Read more...] about Alexza Pharmaceuticals announces promotions

Inhaled drug developer Aradigm has announced the appointment of Robert A. Reed as VP, Regulatory (CMC) and Quality. Reed was most recently Senior VP of CMC and Technical Operations at Celsion Corporation and has also previously held positions at XenoPort and Merck. Aradigm President and CEO Igor Gonda commented, “We are delighted that Dr. Reed has joined our team … [Read more...] about Aradigm appoints Robert A. Reed VP, Regulatory and Quality

Respiratory drug developer Vectura has announced the appointment of former Almirall Executive Director of R&D Per-Olof Andersson as a Non-Executive Director of the Board. Before Almirall, he worked for almost two decades for Pharmacia and Pfizer. Andersson retired from Almirall in 2011 and has been working as an independent consultant since that time. Vectura … [Read more...] about Vectura appoints Per-Olof Andersson as Non-Executive Director

Arikayce inhaled liposomal amikacin developer Insmed Incorporated has announced the appointment of Eugene Sullivan, a former FDA Deputy Director of the Division of Pulmonary and Allergy Products, as Chief Medical and Scientific Officer. Sullivan has also served as Chief Medical Officer of United Therapeutics and VP, Global Regulatory Affairs at Astra Zeneca. … [Read more...] about Insmed appoints Eugene Sullivan Chief Medical and Scientific Officer

Swedish CDMO Recipharm has announced the appointment of Thomas Beck to the new senior role of Vice President Quality Management, effective April 1, 2015. Beck has been Head of Quality Control and Assurance at Recipharm Stockholm since 2010 and also serves as chairman of the Quality Assurance section of the Swedish Academy of Pharmaceutical Science. Recipharm offers … [Read more...] about Recipharm names Thomas Beck as VP Quality Management

Dance Biopharm has announced the appointment of former Dynavax chief medical officer and president J. Tyler Martin as President, a newly created position. Martin has also been appointed a member of the board of directors. From 2003-2006, Martin was a vice president of Chiron, where he worked on the development of Tobi tobramycin inhalation powder. Dance Chairman … [Read more...] about Tyler Martin joins Dance Biopharm as President

DPI developer Respira Therapeutics has hired inhalation drug development pioneer Andy Clark as Vice President and Chief Technology Officer. Clark most recently served as Site Head and CTO at the Novartis pulmonary development facility in San Carlos, CA. He previously served as CTO at Nektar/Inhale and held positions at Genentech and Fisons. Clark, a past president … [Read more...] about Respira hires Andy Clark as VP and Chief Technology Officer

Lightlake Therapeutics has announced today that it has hired former Mundipharma Head of Medical Affairs for New Products Arvind Agrawal as Executive VP, Medical Affairs, effective January 2015. Agrawal has also held Medical Affairs positions at Reckitt Benckiser and AstraZeneca. In December 2014, Lightlake announced that it had licensed its intranasal naloxone … [Read more...] about Arvind Agrawal joins Lightlake Therapeutics